Imagion Biosystems Limited (ASX:IBX)
Australia · Delayed Price · Currency is AUD 0.0080
0.00 (0.00%)
Sep 7, 2026, 9:59 AM AEST
Imagion Biosystems Market Cap
Imagion Biosystems has a market cap or net worth of 4.32 million as of September 4, 2026. Its market cap has increased by 9.59% in one year.
Market Cap
4.32M
Enterprise Value
6.48M
Revenue
573.23K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
ChartMarket Cap Chart
Since June 22, 2017, Imagion Biosystems's market cap has decreased from 32.65M to 4.32M, a decrease of -86.77%. That is a compound annual growth rate of -19.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 6, 2026 | 4.32M | -64.46% |
| Dec 31, 2025 | 12.15M | 162.45% |
| Dec 31, 2024 | 4.63M | -60.04% |
| Dec 29, 2023 | 11.59M | -56.93% |
| Dec 30, 2022 | 26.91M | -68.41% |
| Dec 31, 2021 | 85.20M | -41.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 508.88M |
| Healius | 330.40M |
| Monash IVF Group | 315.60M |
| Cryosite | 61.01M |
| Microba Life Sciences | 38.52M |
| Rhythm Biosciences | 30.79M |
| INOVIQ | 26.04M |
| BCAL Diagnostics | 25.44M |